• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Overview
    • Buy Sell Zone
    • Financials
    • News
      All News Earnings Calls Corporate Announcements Research Reports
    • Reports
    • Technicals
      Technicals Share Price History Delivery
    • Shareholding
      Shareholding Monthly MF Holdings Bulk Block Deals Insider Trading & SAST
    • Deals
      Bulk Block Deals Insider Trading & SAST
    • Corporate Actions
      All Dividend Bonus Split Rights Board Meetings
    • Alerts (3)
    • About

    Alembic Pharmaceuticals Ltd.

    NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
    US FDA Approval
    | Expensive Performer
    972.1000 0.90 (0.09%)
    NSE May 23, 2025 15:31 PM
    25.45% Fall from 52W High
    Volume: 126.8K
    High vol. this week
    • Share on Facebook
    • Tweet
    • Share on LinkedIn
    • Share via Whatsapp

    logo
    Alembic Pharmaceuticals Ltd.
    29 Apr 2025
    US FDA Approval
    972.10
    0.09%
    Alembic Pharmaceuticals Ltd - 533573 - Announcement Under Regulation 30 Of SEBI Regulations, 2015
    BSE India
    Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav
    pdf
    Copy Link Share on Share on Share on Share on
    Alert
    More from Alembic Pharmaceuticals Ltd.
    Recommended
    Five Interesting Stocks Today - May 23, 2025
    The Baseline | 23 May 2025, 05:22PM
    Market closes higher, BEML's Q4 net profit grows 12% YoY to Rs 287.6 crore
    Trendlyne Marketwatch | 23 May 2025, 04:07PM
    Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
    | 22 Jul 2020, 06:11PM
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd